Biological Functions of the Genes in the Mammaprint Breast Cancer Profile Reflect the Hallmarks of Cancer von Tian, Sun, Roepman, Paul, van't Veer, Laura J, Bernards, Rene, De Snoo, Femke, Glas, Annuska M

Volltext

Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular S... von Whitworth, Pat, Beitsch, Peter, Mislowsky, Angela, Pellicane, James V., Nash, Charles, Murray, Mary, Lee, Laura A., Dul, Carrie L., Rotkis, Michael, Baron, Paul, Stork-Sloots, Lisette, de Snoo, Femke A., Beatty, Jennifer

Volltext

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) von Whitworth, Pat, Stork-Sloots, Lisette, de Snoo, Femke A., Richards, Paul, Rotkis, Michael, Beatty, Jennifer, Mislowsky, Angela, Pellicane, James V., Nguyen, Bichlien, Lee, Laura, Nash, Charles, Gittleman, Mark, Akbari, Stephanie, Beitsch, Peter D.

Volltext

Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families von van der Rhee, Jasper I., MD, de Snoo, Femke A., MD, PhD, Vasen, Hans F.A., MD, PhD, Mooi, Wolter J., MD, PhD, Putter, Hein, PhD, Gruis, Nelleke A., PhD, Kukutsch, Nicole A., MD, PhD, Bergman, Wilma, MD, PhD

Volltext

Selection criteria for genetic assessment of patients with familial melanoma von Leachman, Sancy A., MD, PhD, Carucci, John, MD, PhD, Kohlmann, Wendy, MS, Banks, Kimberly C., MS, Asgari, Maryam M., MD, Bergman, Wilma, MD, Bianchi-Scarrà, Giovanna, PhD, Brentnall, Teresa, MD, Bressac-de Paillerets, Brigitte, PharmD, Bruno, William, MD, Curiel-Lewandrowski, Clara, MD, de Snoo, Femke A., PhD, Debniak, Tadeusz, MD, Demierre, Marie-France, MD, Elder, David, MBChB, Goldstein, Alisa M., PhD, Grant-Kels, Jane, MD, Halpern, Allan C., MD, Ingvar, Christian, MD, PhD, Kefford, Richard F., MBBS, PhD, Lang, Julie, MD, MacKie, Rona M., MD, Mann, Graham J., MBBS, PhD, Mueller, Kurt, MD, Newton-Bishop, Julia, MD, Olsson, Håkan, MD, Petersen, Gloria M., PhD, Puig, Susana, MD, Rigel, Darrell, MD, Swetter, Susan M., MD, Tucker, Margaret A., MD, Yakobson, Emanuel, PhD, Zitelli, John A., MD, Tsao, Hensin, MD, PhD

Volltext

Cutaneous melanoma susceptibility and progression genes von de Snoo, Femke A., Hayward, Nicholas K.

Volltext

Genetic testing in familial melanoma: uptake and implications von de Snoo, Femke A., Riedijk, Samantha R., van Mil, Anneke M., Bergman, Wilma, ter Huurne, Jeanet A.C., Timman, Reinier, Bertina, Wieke, Gruis, Nelleke A., Vasen, Hans F.A., van Haeringen, Arie, Breuning, Martijn H., Tibben, Aad

Volltext

From sporadic atypical nevi to familial melanoma: Risk analysis for melanoma in sporadic atypical nevus patients von de Snoo, Femke A., MD, Kroon, Marije W., MSc, Bergman, Wilma, MD, ter Huurne, Jeanet A.C., MSc, Houwing-Duistermaat, Jeanine J., PhD, van Mourik, Leny, Snels, Dyon G.C.T.M., MD, Breuning, Martijn H., MD, Willemze, Rein, MD, Frants, Rune R., PhD, Gruis, Nelleke A., PhD

Volltext

Genome-Wide Analysis of Gene and Protein Expression of Dysplastic Naevus Cells von Gao, Linda, van Nieuwpoort, Frans A., Out-Luiting, Jacoba J., Hensbergen, Paul J., de Snoo, Femke A., Bergman, Wilma, van Doorn, Remco, Gruis, Nelleke A.

Volltext

Pancreatic Carcinoma in Carriers of a Specific 19 Base Pair Deletion of CDKN2A/p16 (p16-Leiden) von DE VOS TOT NEDERVEEN CAPPEL, Wouter H, OFFERHAUS, G. Johan A, MORREAU, Hans, VAN PUIJENBROEK, Marjo, CASPERS, Eric, GRUIS, Nelleke A, DE SNOO, Femke A, LAMERS, Cornelis B. H. W, GRIFFIOEN, Gerrit, BERGMAN, Wilma, VASEN, Hans F. A

Volltext

Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy von Glück, Stefan, de Snoo, Femke, Peeters, Justine, Stork-Sloots, Lisette, Somlo, George

Volltext

Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups von Yao, Katharine, Goldschmidt, Robert, Turk, Mary, Wesseling, Jelle, Stork-Sloots, Lisette, de Snoo, Femke, Cristofanilli, Massimo

Volltext

Familial melanoma: a complex disorder leading to controversy on DNA testing von de Snoo, Femke A, Bergman, Wilma, Gruis, Nelleke A

Volltext

Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) von Beitsch, Peter, Whitworth, Pat, Baron, Paul, Rotkis, Michael C., Mislowsky, Angela M., Richards, Paul D., Murray, Mary K., Pellicane, James V., Dul, Carrie L., Nash, Charles H., Stork-Sloots, Lisette, de Snoo, Femke, Untch, Sarah, Lee, Laura A.

Volltext

Molecular subtyping to predict better clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine with or without trastuzumab von Gluck, Stefan, Royce, Melanie, Stork-Sloots, Lisette, De Snoo, Femke

Volltext

What’s New in Decoding Breast Cancer von de Snoo, Femke

Volltext

Prospective study to measure the impact of MMprofiler on treatment intention in newly diagnosed multiple myeloma patients (PROMMIS) von Hari, Parameswaran, Lentzsch, Suzanne, Siegel, David Samuel DiCapua, Usmani, Saad Zafar, Dhakal, Binod, Rossi, Adriana C., Rosenbaum, Cara Ann, Leng, Siyang, Bhutani, Divaya, Biran, Noa, Vesole, David H., Bhutani, Manisha, Stork-Sloots, Lisette, De Snoo, Femke, Dumee, Belinda C., Van Vliet, Martin, Niesvizky, Ruben

Volltext

Biomarker panel (TheraPrint) analyzed as a predictor of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer von Beitsch, Peter D., Stork, Lisette, De Snoo, Femke, Peeters, Justine, Whitworth, Pat W.

Volltext

Chemosensitivity and endocrine sensitivity predicted by mammaprint and blueprint in the Neoadjuvant Breast Registry Symphony Trial (NBRST) von Whitworth, Pat W., Gittleman, Mark, Akbari, Stephanie, Stork, Lisette, De Snoo, Femke, Gibson, Jessica, Beitsch, Peter D.

Volltext

Gene expression panel (TheraPrint) analyzed as predictors of response to neoadjuvant chemotherapy (NCT) in patients (pts) with stage II-III and inflammatory breast cancer (BC) von Somlo, George, De Snoo, Femke, Peeters, Justine, Stork-Sloots, Lisette, Simon, Iris, Robinson, Kim

Volltext